LEP and Cowden disease: To date, it remains elusive how mesenteric fat and fat-derived leptin shape systemic inflammation in CD and very few clinical scenarios exist, in which the administration of recombinant adipokines is justified and in which their immune modulatory function can be studied in human pathophysiology.